Cargando…

Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis

AIM: Japanese encephalitis (JE) virus is the leading cause of viral neurologic disease and disability in Asia. In the present study JE virus-specific IgM in serum and CSF from acute encephalitis syndrome (AES) patients, attending Assam Medical College and Hospital (AMC and H), Dibrugarh, Assam from...

Descripción completa

Detalles Bibliográficos
Autores principales: Borthakur, AK, Das, Nibedita, Bora, BJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703214/
https://www.ncbi.nlm.nih.gov/pubmed/23853435
http://dx.doi.org/10.4103/0974-777X.112294
_version_ 1782275874050015232
author Borthakur, AK
Das, Nibedita
Bora, BJ
author_facet Borthakur, AK
Das, Nibedita
Bora, BJ
author_sort Borthakur, AK
collection PubMed
description AIM: Japanese encephalitis (JE) virus is the leading cause of viral neurologic disease and disability in Asia. In the present study JE virus-specific IgM in serum and CSF from acute encephalitis syndrome (AES) patients, attending Assam Medical College and Hospital (AMC and H), Dibrugarh, Assam from 2007 to 2009 were detected and different epidemiological parameters namely age, season and vaccination campaign were enumerated. MATERIALS AND METHODS: A cross-sectional study on patients with AES admitted in AMC and H, Dibrugarh, Assam was done during 2007 to 2009. The different epidemiological features were characterized depending on a pretested structured questionnaire called the clinical information form (CIF). Serum and CSF obtained were tested by a Panbio JE-Dengue IgM Combo ELISA kit and JEV Chex kit (Xycton). STATISTICAL ANALYSIS: A z-test was used for the statistical analytic assessment. RESULTS: Detection rate of JE was 39.4%, 51.1%, and 51.3% in the years 2007, 2008, and 2009 respectively. Cases of JE increased in the age group more than 15 years in the district where the vaccination program was undertaken. This increase of cases from pediatric to adults is also statistically significant by the z-test (P<0.05). CONCLUSION: There was an increase in AES cases and also JE cases from 2007 to 2009. JE also showed a seasonal variation with maximum cases in the months of July and August. Although vaccination campaigns with the live attenuated vaccine SA-14-14-2 have started and are protecting the under-15 children, there is a shift of disease pattern in the older population.
format Online
Article
Text
id pubmed-3703214
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37032142013-07-12 Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis Borthakur, AK Das, Nibedita Bora, BJ J Glob Infect Dis Clinical Epidemiology AIM: Japanese encephalitis (JE) virus is the leading cause of viral neurologic disease and disability in Asia. In the present study JE virus-specific IgM in serum and CSF from acute encephalitis syndrome (AES) patients, attending Assam Medical College and Hospital (AMC and H), Dibrugarh, Assam from 2007 to 2009 were detected and different epidemiological parameters namely age, season and vaccination campaign were enumerated. MATERIALS AND METHODS: A cross-sectional study on patients with AES admitted in AMC and H, Dibrugarh, Assam was done during 2007 to 2009. The different epidemiological features were characterized depending on a pretested structured questionnaire called the clinical information form (CIF). Serum and CSF obtained were tested by a Panbio JE-Dengue IgM Combo ELISA kit and JEV Chex kit (Xycton). STATISTICAL ANALYSIS: A z-test was used for the statistical analytic assessment. RESULTS: Detection rate of JE was 39.4%, 51.1%, and 51.3% in the years 2007, 2008, and 2009 respectively. Cases of JE increased in the age group more than 15 years in the district where the vaccination program was undertaken. This increase of cases from pediatric to adults is also statistically significant by the z-test (P<0.05). CONCLUSION: There was an increase in AES cases and also JE cases from 2007 to 2009. JE also showed a seasonal variation with maximum cases in the months of July and August. Although vaccination campaigns with the live attenuated vaccine SA-14-14-2 have started and are protecting the under-15 children, there is a shift of disease pattern in the older population. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3703214/ /pubmed/23853435 http://dx.doi.org/10.4103/0974-777X.112294 Text en Copyright: © Journal of Global Infectious Diseases http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Epidemiology
Borthakur, AK
Das, Nibedita
Bora, BJ
Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis
title Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis
title_full Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis
title_fullStr Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis
title_full_unstemmed Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis
title_short Data from the World Health Organization (WHO) National Network Laboratory for Japanese Encephalitis
title_sort data from the world health organization (who) national network laboratory for japanese encephalitis
topic Clinical Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703214/
https://www.ncbi.nlm.nih.gov/pubmed/23853435
http://dx.doi.org/10.4103/0974-777X.112294
work_keys_str_mv AT borthakurak datafromtheworldhealthorganizationwhonationalnetworklaboratoryforjapaneseencephalitis
AT dasnibedita datafromtheworldhealthorganizationwhonationalnetworklaboratoryforjapaneseencephalitis
AT borabj datafromtheworldhealthorganizationwhonationalnetworklaboratoryforjapaneseencephalitis